Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019.

Stephanie A RichardNusrat J EpsiSimon PollettDavid A LindholmAllison M W MalloyRyan MavesGregory C UtzTahaniyat LalaniAlfred G SmithRupal M ModyAnuradha GanesanRhonda E ColomboChristopher J ColomboSharon W ChiNikhil HuprikarDerek T LarsonSamantha BazanCristian MadarCharlotte LanteriJulia S RozmanCaroline EnglishKatrin MendeDavid R TribbleBrian K AganTimothy H BurgessJohn H Powersnull null

Published in: Open forum infectious diseases (2021)

FLU-PRO Plus performs well in measuring signs and symptoms in SARS-CoV-2 infection with excellent construct validity, known-groups validity, and responsiveness to change. Standardized data collection instruments facilitate meta-analyses, vaccine effectiveness studies, and other COVID-19 research activities.

Keyphrases

patient reported outcomes
coronavirus disease
meta analyses
respiratory syndrome coronavirus
systematic review
randomized controlled trial
anti inflammatory
sars cov
electronic health record
big data
sleep quality
depressive symptoms
machine learning
physical activity